FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to method of producing artificial skin. Method of producing artificial skin, including epidermal basal membrane containing continuous dark plate (lamina densa) and anchor fibre, outgoing from lamina densa and derma, containing collagen fibres, which involves adding an inhibitor of matrix metalloproteinase and heparanase inhibitor to culture medium for formation of artificial leather, containing human keratinocytes epidermis and derma fibroblasts; culturing cells in culture medium for formation of artificial leather and formation of artificial leather. Artificial skin. Agent stimulating formation of dark plate (lamina densa) and anchor fibres associated with dark plate containing matrix metalloproteinase inhibitor and heparanase inhibitor. Agent stimulating formation of bulging on surface of cell membranes (fibripositors) and formation of dark plate (lamina densa) and anchor fibres associated with dark plate containing matrix metalloproteinase inhibitor and heparanase inhibitor. Agent stimulating formation of elastin fibres and formation of dark plate (lamina densa) and anchor fibres associated with dark plate containing matrix metalloproteinase inhibitor and heparanase inhibitor. Agent stimulating regeneration and recovery of epidermal basal membrane and derma and formation of dark plate (lamina densa) and anchor fibres associated with dark plate containing matrix metalloproteinase inhibitor and heparanase inhibitor.
EFFECT: method described above enables to obtain artificial skin, close to natural skin.
10 cl, 3 dwg, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
HEPARANASA ACTIVITY INHIBITOR | 2010 |
|
RU2503454C1 |
REGENERATION OF DAMAGED TISSUE | 2014 |
|
RU2677637C2 |
XIKVAV PEPTIDE APPLICATION IN PRODUCTION OF COSMETIC COMPOSITIONS FOR SKIN TIGHTNESS ENHANCEMENT DUE TO IMPROVED CELL ADHESION | 2005 |
|
RU2371167C2 |
ENGINEERED LEATHER EQUIVALENT, METHOD FOR PRODUCTION THEREOF AND PRODUCTS OBTAINED THEREFROM | 2017 |
|
RU2820590C2 |
COMPOSITION FOR REDUCING SKIN AGEING DISORDERS, COMPRISING RETINALDEHYDE AND LEONTOPODIUM ALPINUM EXTRACT | 2014 |
|
RU2675702C1 |
METHOD OF TREATING PATIENT'S ORAL DISEASES (VERSIONS) | 2007 |
|
RU2498808C9 |
SKIN EQUIVALENT AND METHOD FOR ITS PRODUCTION | 2006 |
|
RU2342164C2 |
THERAPY OF DEEP BURN OF SKIN | 2008 |
|
RU2372922C1 |
GEL OF HYALURONIC ACID FOR INTRACUTANEOUS INJECTION | 2007 |
|
RU2448740C2 |
OCCLUDER FOR TRANSCUTANEOUS TRANSLUMINAL PROCEDURE (VERSIONS), METHOD OF TRANSCUTANEOUS TRANSLUMINAL CLOSING OF HOLE IN HEART, METHOD OF ACTIVISATION OF MAMMALIAN TISSUE VASCULARISATION IN VIVO AND METHOD OF ACTIVISATION OF ANASTOMOSIS PLACE HEALING | 2007 |
|
RU2470611C2 |
Authors
Dates
2016-08-10—Published
2011-01-19—Filed